NEOG logo

NEOGEN CORP

NEOGNASDAQ
πŸ† #1706 by market capEarnings Jan 6US Equity
$12.25β–² $0.13 (+1.07%)
Market closed Β· at close
πŸ””
Track NEOG
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.1%
7dβ–² 0.6%
14dβ–² 3.6%
30dβ–Ό 4.2%
ytdβ–² 75.4%
1yβ–² 103.8%
🏦Market Cap
$2.67B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-0.3%
Declining
πŸ“ŠGross Margin
47.4%
Healthy
πŸ’΅FCF Margin
5.6%
Moderate
βš–οΈP/S Ratio
3.0x
Fair
Otter Score
56
Fair

Trading Snapshot

Day Range
$12.06 – $12.37
52-Week Range
$5.37 – $14.26
Volume (shares)
218,543
Avg Volume (shares)
β€”
Shares Outstanding
218.3M
Next Earnings
2027-01-06

Fundamentals Snapshot

Annual Revenue
$870M
Last Q Revenue
$223M
P/E Ratio
β€”
P/S Ratio
3.0x
EPS (TTM)
$-0.26
Dividend Yield
β€”
Dilution (1yr)
+0.3%
NEOG logo

NEOGEN CORP

NEOG
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$870Mβ–Ό βˆ’2.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
46.9%β–Ό βˆ’0.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$22Mβ–Ό βˆ’329.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$32Mβ–Ό βˆ’168.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
218.1Mβ–² +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$602Mβ–² +$45M YoY
StockOtter Β· stockotter.space

About NEOGEN CORP

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
56/100

Analyst Ratings

β“˜
Consensus
Buy
11 analysts
Strong Buy3
Buy5
Hold3
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.